2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
US6762170B1 · kind B1 · utility
4Cited by
29References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2000 |
| Grant date | Jul 13, 2004 |
| Priority date | — |
| Expiry date | Jul 31, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided according to the invention, novel compounds of formula (I) wherein R1, R2 and R3 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.